The Level of Anti-Polyethylene Glycol

The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2023-06, Vol.175 (2), p.270
Hauptverfasser: Zima, A.P, Gurev, A.M, Nevskaya, K.V, Baikov, A.N, Krivoshchekov, S.V, Pershina, A.G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 270
container_title Bulletin of experimental biology and medicine
container_volume 175
creator Zima, A.P
Gurev, A.M
Nevskaya, K.V
Baikov, A.N
Krivoshchekov, S.V
Pershina, A.G
description The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG. Key Words: monocytes; polyethylene glycol; anti-PEG IgG antibody; magnetic nanoparticles; solid lipid nanoparticles
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_healthsolutions_A765450779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765450779</galeid><sourcerecordid>A765450779</sourcerecordid><originalsourceid>FETCH-gale_healthsolutions_A7654507793</originalsourceid><addsrcrecordid>eNpjYeA0MDAw1zWxsLDgYOAqLs4CcQ3MDDkZVEMyUhV8UstScxTy0xQc80oydQPycypTSzIqc1LzUhXccyqT83N4GFjTEnOKU3mhNDeDmptriLOHbnpiTmp8RmpiTklGcX5OaUlmfl5xvKO5mamJqYG5uaUx0QoBlvcwTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Level of Anti-Polyethylene Glycol</title><source>SpringerLink Journals</source><creator>Zima, A.P ; Gurev, A.M ; Nevskaya, K.V ; Baikov, A.N ; Krivoshchekov, S.V ; Pershina, A.G</creator><creatorcontrib>Zima, A.P ; Gurev, A.M ; Nevskaya, K.V ; Baikov, A.N ; Krivoshchekov, S.V ; Pershina, A.G</creatorcontrib><description>The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG. Key Words: monocytes; polyethylene glycol; anti-PEG IgG antibody; magnetic nanoparticles; solid lipid nanoparticles</description><identifier>ISSN: 0007-4888</identifier><language>eng</language><publisher>Springer</publisher><subject>Antigen-antibody reactions ; Biological products ; Immunoglobulin G ; Polyethylene glycol</subject><ispartof>Bulletin of experimental biology and medicine, 2023-06, Vol.175 (2), p.270</ispartof><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Zima, A.P</creatorcontrib><creatorcontrib>Gurev, A.M</creatorcontrib><creatorcontrib>Nevskaya, K.V</creatorcontrib><creatorcontrib>Baikov, A.N</creatorcontrib><creatorcontrib>Krivoshchekov, S.V</creatorcontrib><creatorcontrib>Pershina, A.G</creatorcontrib><title>The Level of Anti-Polyethylene Glycol</title><title>Bulletin of experimental biology and medicine</title><description>The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG. Key Words: monocytes; polyethylene glycol; anti-PEG IgG antibody; magnetic nanoparticles; solid lipid nanoparticles</description><subject>Antigen-antibody reactions</subject><subject>Biological products</subject><subject>Immunoglobulin G</subject><subject>Polyethylene glycol</subject><issn>0007-4888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYeA0MDAw1zWxsLDgYOAqLs4CcQ3MDDkZVEMyUhV8UstScxTy0xQc80oydQPycypTSzIqc1LzUhXccyqT83N4GFjTEnOKU3mhNDeDmptriLOHbnpiTmp8RmpiTklGcX5OaUlmfl5xvKO5mamJqYG5uaUx0QoBlvcwTg</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Zima, A.P</creator><creator>Gurev, A.M</creator><creator>Nevskaya, K.V</creator><creator>Baikov, A.N</creator><creator>Krivoshchekov, S.V</creator><creator>Pershina, A.G</creator><general>Springer</general><scope/></search><sort><creationdate>20230601</creationdate><title>The Level of Anti-Polyethylene Glycol</title><author>Zima, A.P ; Gurev, A.M ; Nevskaya, K.V ; Baikov, A.N ; Krivoshchekov, S.V ; Pershina, A.G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_healthsolutions_A7654507793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antigen-antibody reactions</topic><topic>Biological products</topic><topic>Immunoglobulin G</topic><topic>Polyethylene glycol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zima, A.P</creatorcontrib><creatorcontrib>Gurev, A.M</creatorcontrib><creatorcontrib>Nevskaya, K.V</creatorcontrib><creatorcontrib>Baikov, A.N</creatorcontrib><creatorcontrib>Krivoshchekov, S.V</creatorcontrib><creatorcontrib>Pershina, A.G</creatorcontrib><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zima, A.P</au><au>Gurev, A.M</au><au>Nevskaya, K.V</au><au>Baikov, A.N</au><au>Krivoshchekov, S.V</au><au>Pershina, A.G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Level of Anti-Polyethylene Glycol</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><date>2023-06-01</date><risdate>2023</risdate><volume>175</volume><issue>2</issue><spage>270</spage><pages>270-</pages><issn>0007-4888</issn><abstract>The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG. Key Words: monocytes; polyethylene glycol; anti-PEG IgG antibody; magnetic nanoparticles; solid lipid nanoparticles</abstract><pub>Springer</pub></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2023-06, Vol.175 (2), p.270
issn 0007-4888
language eng
recordid cdi_gale_healthsolutions_A765450779
source SpringerLink Journals
subjects Antigen-antibody reactions
Biological products
Immunoglobulin G
Polyethylene glycol
title The Level of Anti-Polyethylene Glycol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A52%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Level%20of%20Anti-Polyethylene%20Glycol&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Zima,%20A.P&rft.date=2023-06-01&rft.volume=175&rft.issue=2&rft.spage=270&rft.pages=270-&rft.issn=0007-4888&rft_id=info:doi/&rft_dat=%3Cgale%3EA765450779%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A765450779&rfr_iscdi=true